Zhongtang Lu

435 total citations
8 papers, 370 citations indexed

About

Zhongtang Lu is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Zhongtang Lu has authored 8 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Hepatology. Recurrent topics in Zhongtang Lu's work include Cancer, Hypoxia, and Metabolism (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Zhongtang Lu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Zhongtang Lu collaborates with scholars based in China and United States. Zhongtang Lu's co-authors include Xin Zheng, Kangsheng Tu, Yingmin Yao, Qingguang Liu, Xiaohong Gai, Chao Li, Cheng Guo, Wei Yang, Zheyong Liang and Qingguang Liu and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecular Cancer.

In The Last Decade

Zhongtang Lu

8 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongtang Lu China 7 275 137 99 98 39 8 370
Ramona Rudalska Germany 4 351 1.3× 142 1.0× 71 0.7× 131 1.3× 35 0.9× 6 435
Hui Rao China 10 299 1.1× 125 0.9× 77 0.8× 103 1.1× 31 0.8× 19 439
Xiaohong Gai China 9 250 0.9× 89 0.6× 65 0.7× 103 1.1× 30 0.8× 9 349
Qianze Dong China 13 320 1.2× 122 0.9× 63 0.6× 83 0.8× 27 0.7× 17 418
Chengyao Xie China 12 249 0.9× 76 0.6× 82 0.8× 98 1.0× 48 1.2× 18 341
Shunsuke Ebara Japan 7 208 0.8× 88 0.6× 65 0.7× 68 0.7× 21 0.5× 15 325
Yun Seong Jeong United States 9 397 1.4× 143 1.0× 44 0.4× 147 1.5× 24 0.6× 17 499
Fubo Ji China 5 196 0.7× 95 0.7× 136 1.4× 83 0.8× 19 0.5× 11 355
Jiequn Ma China 13 255 0.9× 149 1.1× 35 0.4× 110 1.1× 41 1.1× 19 376
Xian-Zi Yang China 8 225 0.8× 95 0.7× 30 0.3× 95 1.0× 21 0.5× 8 320

Countries citing papers authored by Zhongtang Lu

Since Specialization
Citations

This map shows the geographic impact of Zhongtang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongtang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongtang Lu more than expected).

Fields of papers citing papers by Zhongtang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongtang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongtang Lu. The network helps show where Zhongtang Lu may publish in the future.

Co-authorship network of co-authors of Zhongtang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongtang Lu. A scholar is included among the top collaborators of Zhongtang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongtang Lu. Zhongtang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Yao, Yingmin, et al.. (2015). MACC1 Suppresses Cell Apoptosis in Hepatocellular Carcinoma by Targeting the HGF/c-MET/AKT Pathway. Cellular Physiology and Biochemistry. 35(3). 983–996. 44 indexed citations
2.
Tu, Kangsheng, Wei Yang, Chao Li, et al.. (2014). Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Molecular Cancer. 13(1). 110–110. 151 indexed citations
3.
Gai, Xiaohong, Kangsheng Tu, Zhongtang Lu, & Xin Zheng. (2014). MRC2 Expression Correlates with TGFβ1 and Survival in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 15(9). 15011–15025. 35 indexed citations
4.
Ji, Dong, Zhongtang Lu, Zheyong Liang, et al.. (2014). MACC1 Expression Correlates with PFKFB2 and Survival in Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention. 15(2). 999–1003. 33 indexed citations
5.
Gai, Xiaohong, Zhongtang Lu, Kangsheng Tu, Zheyong Liang, & Xin Zheng. (2014). Caveolin-1 Is Up-Regulated by GLI1 and Contributes to GLI1-Driven EMT in Hepatocellular Carcinoma. PLoS ONE. 9(1). e84551–e84551. 40 indexed citations
6.
Wang, Yuan, et al.. (2014). [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].. PubMed. 30(10). 1076–9. 5 indexed citations
7.
Zheng, Xin, Xiaohong Gai, Zhongtang Lu, et al.. (2013). Histone acetyltransferase PCAF Up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling. Molecular Cancer. 12(1). 96–96. 42 indexed citations
8.
Lu, Zhongtang, Zheyong Liang, Dong Ji, et al.. (2012). Metastasis-associated in colon cancer-1 is associated with poor prognosis in hepatocellular carcinoma, partly by promoting proliferation through enhanced glucose metabolism. Molecular Medicine Reports. 12(1). 426–434. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026